4th July 2008
Ultrasis plc, the provider of computer-delivered, interactive healthcare products and associated services, has appointed JBP to lead its financial PR, investor relations and corporate, trade and consumer communications.
The appointment is made as AIM-listed Ultrasis embarks on a major rollout of its flagship product designed to treat anxiety and depression, Beating the Blues, to a wider retail audience.
It will ensure that key stakeholders in the company are kept fully informed about the company’s plans to consolidate its leadership role in the development of health and psychology software programmes targeted at the NHS, the corporate sector and individual end users.
Beating the Blues is an eight-week, web-based treatment programme for depression based on Cognitive Behavioural Therapy (CBT) which, following rigorous assessment was approved by NICE (National Institute for Health and Clinical Excellence) for use in the NHS in February 2006.
It is available to private patients as Beating the Blues Connect, with 24/7 telephone support.
Nigel Brabbins, Chief Executive of Ultrasis plc said: “We want to make sure that our potential investors, analysts, employees, customers and the media are kept fully abreast of some fast moving developments which is why JBP has come on board to lead a wider strategic communications programme, targeting both existing customers and new, private ones.”
Karen White, Director, JBP, said: “This is an innovative product in a very dynamic sector. We are very much looking forward to working hand in hand with the Ultrasis board to bring their product range to a much more diverse audience.”
Financial communications will be handled by JBP's investor relations division, Performance Communications.